Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG

Malin K.B. Jonsson, Marc A. Vos, Gary R. Mirams, Göran Duker, Peter Sartipy, Teun P. de Boer, Toon A.B. van Veen
  • Journal of Molecular and Cellular Cardiology, May 2012, Elsevier
  • DOI: 10.1016/j.yjmcc.2012.02.002

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.yjmcc.2012.02.002

The following have contributed to this page: Dr Gary R Mirams